MoneyWorks4Me

Cipla reports 12% rise in Q2 consolidated net profit

05 Nov 2022 Evaluate

Cipla has reported results for second quarter ended September 30, 2022.

The company has reported a fall of 7.93% in its net profit at Rs 720.30 crore for the quarter under review as compared to Rs 782.37 crore for the same quarter in the previous year. However, total income of the company increased by 5.53% at Rs 4243.55 crore for Q2FY23 as compared Rs 4021.18 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported rise of 12.45% in its net profit at Rs 797.41 crore for the quarter under review as compared to Rs 709.15 crore for the same quarter in the previous year. Total income of the company increased by 6.65% at Rs 5951.49 crore for Q2FY23 as compared Rs 5580.47 crore for the corresponding quarter previous year.


Peers
Company Name CMP
Sun Pharma. Inds. 1840.00
Dr. Reddys Labs. 1222.50
Cipla 1388.90
Lupin 2061.85
Zydus Lifesciences 1212.00
View more..